Table 1.
Healthy Controls | HCV+ (F0-2)1 | HCV+ (F3-4)2 | |
---|---|---|---|
Number | 13 | 9 | 4 |
Age, avg. years (SD3) | 31.2 (8.4) | 50 (14.9) | 56.5 (4.1) |
Race | Caucasian | Caucasian (7), East Indian (1), African (1) | Caucasian (3), Native (1) |
HCV-RNA (IU/mL) | 3.1 × 106 (2.2 × 106) | 1.6 × 106 (2.2 × 106) | |
HCV genotype4 (n) | 1 (7: 1a n = 3, 1b n = 1), 2b (1) | 1a (3), 3 (1) | |
Fibroscan, avg. kPa5 (SD) | 6.1 (1.9) | 19.3 (7.1) | |
AST6 (U/L) | 25.4 (12.9) | 47.3 (37.3) | |
ALT7 (U/L) | 47.3 (23.6) | 75.0 (42.0) |
1 (F0-2): minimal liver fibrosis (<9.0 kPa); 2 (F3-4) advanced liver fibrosis (>11.0 kPa); 3 SD (standard deviation); 4 not all HCV subgenotypes were known; 5 kPa (kilopascal); 6 AST (Aspartate aminotransferase); 7 ALT (Alanine aminotransferase).